Evidence map›Paper›PMID 23372174›Full record

ArticleBMJ (Clinical research ed.)2013

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.

Alexander Y Walley, Ziming Xuan, H Holly Hackman, Emily Quinn, Maya Doe-Simkins, Amy Sorensen-Alawad, Sarah Ruiz, Al Ozonoff

Abstract readComparative StudyEvaluation StudyMulticenter Study
In one paragraph

Article in BMJ (Clinical research ed.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 495 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
495citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

495 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2022
    Guideline
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.Health technology assessment (Winchester, England) · 2024
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Socioenvironmental disasters and the dialectics of overdose mortality.The International journal on drug policy · 2026
    Article
  20. Article

435 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander Y WalleyClinical Addiction Research Education Unit, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA 02118, USA. awalley@bu.edu
Ziming Xuan
H Holly Hackman
Emily Quinn
Maya Doe-Simkins
Amy Sorensen-Alawad
Sarah Ruiz
Al Ozonoff

Funding

Impact of overdose prevention education and intranasal naloxone on fatal and non-R21CE001602 · CE · BOSTON MEDICAL CENTER · PI WALLEY, ALEXANDER YALE · 2009 to 2010
$350k
NCIPC CDC HHS 1R21CE001602NCIPC CDC HHS 1R21CE001602-01
6 · The paper itself

Abstract

objectiveTo evaluate the impact of state supported overdose education and nasal naloxone distribution (OEND) programs on rates of opioid related death from overdose and acute care utilization in Massachusetts.

designInterrupted time series analysis of opioid related overdose death and acute care utilization rates from 2002 to 2009 comparing community-year strata with high and low rates of OEND implementation to those with no implementation.

setting19 Massachusetts communities (geographically distinct cities and towns) with at least five fatal opioid overdoses in each of the years 2004 to 2006.

participantsOEND was implemented among opioid users at risk for overdose, social service agency staff, family, and friends of opioid users.

interventionOEND programs equipped people at risk for overdose and bystanders with nasal naloxone rescue kits and trained them how to prevent, recognize, and respond to an overdose by engaging emergency medical services, providing rescue breathing, and delivering naloxone.

main outcome measuresAdjusted rate ratios for annual deaths related to opioid overdose and utilization of acute care hospitals.

resultsAmong these communities, OEND programs trained 2912 potential bystanders who reported 327 rescues. Both community-year strata with 1-100 enrollments per 100,000 population (adjusted rate ratio 0.73, 95% confidence interval 0.57 to 0.91) and community-year strata with greater than 100 enrollments per 100,000 population (0.54, 0.39 to 0.76) had significantly reduced adjusted rate ratios compared with communities with no implementation. Differences in rates of acute care hospital utilization were not significant.

conclusionsOpioid overdose death rates were reduced in communities where OEND was implemented. This study provides observational evidence that by training potential bystanders to prevent, recognize, and respond to opioid overdoses, OEND is an effective intervention.

Indexed as

AdultAllied Health PersonnelAnalgesics, OpioidCurriculumDrug OverdoseEmergency Service, HospitalFemaleHarm ReductionHealth EducationHospitalizationHumansMaleMassachusettsNaloxoneNarcotic AntagonistsPrescription DrugsAnalgesics, OpioidNaloxoneNarcotic AntagonistsPrescription Drugs

Identifiers

PMID23372174
PMCPMC4688551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.